Scaling up the UK’s research ambition
June 15, 2009Research and Development NHS, clinical trials, healthcare, patients
The UK has always been one of the world's leaders in drug discovery, with around half of all major medicines …
Icon extends strategic contract from Lilly
June 15, 2009Manufacturing and Production ICON
Irish contract research organisation Icon will manage clinical trial set-up and management for Lilly's European trials in a deal that …
NICE defies pressure and keeps restrictions on Alzheimer’s
June 15, 2009Research and Development Alzheimer's, NICE
Patients with early stage Alzheimer's disease will still be denied access to drug treatment after NICE decided to retain its …
New health secretary promises ‘deep clean’ of NHS priorities
June 15, 2009NHS, healthcare
The new health secretary Andy Burnham has promised a 'deep clean' of the NHS' priorities, with a further move away …
Battle ahead for US industry over biologics patents
June 12, 2009Research and Development, Sales and Marketing PhRMA, US, generics, industry, reform
Moves to make it easier for biosimilars to be approved in the US are gaining momentum.The pharma industry has conceded …
Schering-Plough opens Dutch injectables facility
June 12, 2009Manufacturing and Production Europe, Netherlands
Schering-Plough has opened a new pharmaceutical manufacturing facility in Oss, the Netherlands, to help meet demand for the drugmakers' injectable …
Pandemic declaration will not change UK’s response
June 12, 2009NHS, h1n1
The Department of Health has insisted there will be no "material change" to the UK's preparations for swine flu. The …
Anti-smoking measures boosted by £2.5m grant
June 11, 2009Cancer, NHS
Government anti-smoking measures are to receive a boost with the provision of a £2.5 million grant to help smokers kick …
Genentech forms type I diabetes collaboration
June 11, 2009Research and Development Roche, diabetes
The deal gives the Roche-owned biotech development and marketing rights to Bayhill’s molecule BHT-3021, which is currently in phase I/II …
Time to find and develop your ‘Eureka!’ people
June 11, 2009Business Services diversity, recruitment, training
The big pharma model is broken, and one of the ways drug development companies are going to fix it is …
NHS faces biggest financial challenge of its history
June 10, 2009NHS, healthcare
The NHS is hurtling towards the most severe financial shortfall of its history, and faces an austere future of cutting …
Kendle opens more Asia-Pacific offices
June 10, 2009Research and Development Kendle
Contract research organisation Kendle has opened up new offices in Malaysia, Thailand and the Philippines as part of a continued …
The pharmaceutical industry faces unprecedented barriers to evolution
June 10, 2009Research and Development US, healthcare
Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused …
Sanofi swoops on Pfizer’s insulin plant
June 9, 2009Manufacturing and Production, Research and Development Sanofi-Aventis
Sanofi-Aventis will pay 30 million euros (£26 million) for a manufacturing plant in Germany operated by Pfizer in a deal …
PM Society launches Digital Media Awards
June 9, 2009Business Services, Sales and Marketing pm society
The Pharmaceutical Marketing Society is to showcase the best in digital media across the pharma and healthcare industry at a …
Major Glaxo accounts go to TBWA
June 9, 2009Medical Communications, Sales and Marketing GSK
GlaxoSmithKline has chosen new agencies to handle some of it biggest consumer brands, including Nicorette and weight loss drug Alli. …
The changing role of market research
June 8, 2009Sales and Marketing NHS, marketing research
Market Research and analytics is an area which continues to present new challenges and opportunities for our industry. I first …
Andy Burnham named new health secretary
June 8, 2009NHS, healthcare
Andy Burnham has been named as the government's new secretary of state for health, in Prime Minister Gordon Brown's latest …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
